CT UK Capital and Income Investment Trust PLC is a closed-ended investment company launched in 1992 and domiciled in the United Kingdom. Its primary objective is to achieve long-term capital and income growth through a diversified portfolio mainly comprising FTSE All-Share Index companies, with limited exposure to leading overseas firms not exceeding 10% of gross assets. The trust emphasizes dividend-paying value stocks selected for strong balance sheets, robust cash flows, and growth potential across sectors like financial services, consumer defensive, industrials, healthcare, and real estate, with top holdings including GSK, Unilever, AstraZeneca, Shell, and Imperial Brands. Managed by Columbia Threadneedle Investments, it features a low ongoing charge of 0.67%, modest gearing around 5%, and a consistent dividend yield of approximately 3.7%, paid quarterly in February, May, August, and December. With total assets around £370 million and a market capitalization near £335 million, the trust typically trades at a discount to its net asset value, playing a key role in the UK equity income sector by providing investors access to medium- and large-cap UK businesses focused on sustainable growth and income generation.